Does METOPROLOL Cause Dysarthria? 109 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Dysarthria have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.3% of all adverse event reports for METOPROLOL.
109
Reports of Dysarthria with METOPROLOL
0.3%
of all METOPROLOL reports
4
Deaths
74
Hospitalizations
How Dangerous Is Dysarthria From METOPROLOL?
Of the 109 reports, 4 (3.7%) resulted in death, 74 (67.9%) required hospitalization, and 23 (21.1%) were considered life-threatening.
Is Dysarthria Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Dysarthria?
OLANZAPINE (900)
QUETIAPINE (669)
PREGABALIN (618)
AMLODIPINE (553)
GABAPENTIN (548)
METFORMIN (540)
METHOTREXATE (536)
DIAZEPAM (512)
ASPIRIN (495)
LORAZEPAM (483)
Which METOPROLOL Alternatives Have Lower Dysarthria Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE